Cabaron, Rick Jhon C.
HRN: 24-53-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/31/2024
02/06/2024
IVT
250mg
Q6
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: URTIIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes